Vanguard Group
EXAS icon

Vanguard Group’s Exact Sciences EXAS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$952M Buy
17,907,459
+269,785
+2% +$14.3M 0.02% 699
2025
Q1
$764M Buy
17,637,674
+617,384
+4% +$26.7M 0.01% 776
2024
Q4
$956M Sell
17,020,290
-743,624
-4% -$41.8M 0.02% 676
2024
Q3
$1.21B Sell
17,763,914
-411,357
-2% -$28M 0.02% 598
2024
Q2
$768M Buy
18,175,271
+435,179
+2% +$18.4M 0.01% 753
2024
Q1
$1.23B Buy
17,740,092
+180,341
+1% +$12.5M 0.02% 588
2023
Q4
$1.3B Buy
17,559,751
+115,058
+0.7% +$8.51M 0.03% 554
2023
Q3
$1.19B Sell
17,444,693
-119,581
-0.7% -$8.16M 0.03% 539
2023
Q2
$1.65B Buy
17,564,274
+171,986
+1% +$16.1M 0.04% 460
2023
Q1
$1.18B Buy
17,392,288
+139,823
+0.8% +$9.48M 0.03% 542
2022
Q4
$854M Buy
17,252,465
+575,854
+3% +$28.5M 0.02% 634
2022
Q3
$542M Buy
16,676,611
+698,740
+4% +$22.7M 0.02% 789
2022
Q2
$629M Buy
15,977,871
+335,877
+2% +$13.2M 0.02% 738
2022
Q1
$1.09B Buy
15,641,994
+210,260
+1% +$14.7M 0.03% 606
2021
Q4
$1.2B Buy
15,431,734
+64,700
+0.4% +$5.04M 0.03% 593
2021
Q3
$1.47B Sell
15,367,034
-43,521
-0.3% -$4.15M 0.04% 506
2021
Q2
$1.92B Buy
15,410,555
+307,132
+2% +$38.2M 0.05% 435
2021
Q1
$1.99B Buy
15,103,423
+903,330
+6% +$119M 0.05% 395
2020
Q4
$1.88B Buy
14,200,093
+770,797
+6% +$102M 0.05% 380
2020
Q3
$1.37B Sell
13,429,296
-332,924
-2% -$33.9M 0.05% 422
2020
Q2
$1.2B Sell
13,762,220
-6,652
-0% -$578K 0.04% 442
2020
Q1
$799M Buy
13,768,872
+340,768
+3% +$19.8M 0.03% 504
2019
Q4
$1.24B Buy
13,428,104
+1,564,834
+13% +$145M 0.04% 474
2019
Q3
$1.07B Buy
11,863,270
+341,626
+3% +$30.9M 0.04% 496
2019
Q2
$1.36B Buy
11,521,644
+309,043
+3% +$36.5M 0.05% 414
2019
Q1
$971M Buy
11,212,601
+418,085
+4% +$36.2M 0.04% 509
2018
Q4
$681M Buy
10,794,516
+296,429
+3% +$18.7M 0.03% 580
2018
Q3
$829M Buy
10,498,087
+261,239
+3% +$20.6M 0.03% 574
2018
Q2
$612M Buy
10,236,848
+4,102
+0% +$245K 0.03% 677
2018
Q1
$413M Buy
10,232,746
+177,427
+2% +$7.16M 0.02% 846
2017
Q4
$528M Buy
10,055,319
+339,454
+3% +$17.8M 0.02% 724
2017
Q3
$458M Buy
9,715,865
+256,186
+3% +$12.1M 0.02% 762
2017
Q2
$335M Buy
9,459,679
+700,051
+8% +$24.8M 0.02% 906
2017
Q1
$207M Buy
8,759,628
+528,352
+6% +$12.5M 0.01% 1206
2016
Q4
$110M Buy
8,231,276
+311,306
+4% +$4.16M 0.01% 1566
2016
Q3
$147M Buy
7,919,970
+814,959
+11% +$15.1M 0.01% 1317
2016
Q2
$87M Buy
7,105,011
+428,035
+6% +$5.24M 0.01% 1606
2016
Q1
$45M Sell
6,676,976
-20,551
-0.3% -$139K ﹤0.01% 1915
2015
Q4
$61.8M Buy
6,697,527
+168,353
+3% +$1.55M ﹤0.01% 1784
2015
Q3
$117M Buy
6,529,174
+619,614
+10% +$11.1M 0.01% 1324
2015
Q2
$176M Buy
5,909,560
+187,687
+3% +$5.58M 0.01% 1148
2015
Q1
$126M Buy
5,721,873
+530,913
+10% +$11.7M 0.01% 1345
2014
Q4
$142M Buy
5,190,960
+146,619
+3% +$4.02M 0.01% 1183
2014
Q3
$97.8M Buy
5,044,341
+23,088
+0.5% +$447K 0.01% 1368
2014
Q2
$85.5M Buy
5,021,253
+632,035
+14% +$10.8M 0.01% 1505
2014
Q1
$62.2M Buy
4,389,218
+161,436
+4% +$2.29M 0.01% 1686
2013
Q4
$49.4M Buy
4,227,782
+158,359
+4% +$1.85M ﹤0.01% 1794
2013
Q3
$48.1M Buy
4,069,423
+195,830
+5% +$2.31M ﹤0.01% 1743
2013
Q2
$53.9M Buy
+3,873,593
New +$53.9M 0.01% 1590